ITCASS and ERGECD meeting 2024
Meet us in Liverpool at the the 11th meeting of Immunotoxicology & Chemical Allergy (ITCASS) and the 30th meeting of European Research Group on Experimental Contact Dermatitis (ERGECD).
Meet us in Liverpool at the the 11th meeting of Immunotoxicology & Chemical Allergy (ITCASS) and the 30th meeting of European Research Group on Experimental Contact Dermatitis (ERGECD).
Spotlight on in vitro quantitative assessment of skin sensitizing potency. Join our upcoming webinar to explore the recent advancement in GARD® for quantitative assessment of skin sensitizing potency. This session will present a meta-analysis of GARD® data covering over 200 chemicals, including three blinded datasets generated in collaboration with industry partners. These data will demonstrate […]
Meet us at Booth #56 Come meet us at booth #56 and join our presentations to hear the latest news about GARD® and how the assays are used to fill data gaps in skin sensitizing hazard and quantitative potency assessment. Additionally, meet ToxHub, a SenzaGen Group company, and benefit from expert toxicology and regulatory advice. […]
Spotlight on Point-of-Departure, Challenging Substances, and Active Ingredients We invite you to join our upcoming webinar, where industry leaders from Lundbeck, Unilever, and Cargill, along with experts from SenzaGen will explain the latest advancements in skin sensitization testing. Join us as we explore the latest data from our GARD® platform on skin sensitization and gain […]
Meet us at the American Society for Cellular and Computational Toxicology (ASCCT) Annual Meeting in Research Triangle Park, North Carolina. Oral presentation | Monday, 28 October | 17:20-17:35 NAMs for botanical safety evaluation: Case Study on Determine the Safe Use Levels of Genipa Plant Extract in Temporary Tattoo Ink with GARD® Poster GARD®skin […]
Join us for a special re-run of our popular GARD® webinar to explore the recent advancement in Skin Sensitization testing, focusing on substances that fall outside the applicability domains of the conventional in vitro assays in the OECD Test Guidelines. Our skin sensitization experts will address challenges posed by various "Difficult-to-Test" substances, discussing the applicability […]
Join SenzaGen and industry leaders from Clarins and Bic Skin Creative for an in-depth webinar on using GARD® assays for skin sensitization testing. Learn how this innovative technology overcomes the unique challenges of testing complex Natural Extracts, which often fall outside the scope of traditional methods in OECD 442E Test Guidelines. Through case studies, we will showcase […]
Join us for an insightful webinar on the evolving role of New Approach Methodologies (NAMs) in regulatory biological safety assessments and how they can be used to help develop safe materials in the pre-regulatory space. With shifting standards and increasing adoption of NAMs, understanding their impact is more critical than ever. In this webinar, Dr […]
Booth #637 Orange County Convention Center, Orlando, FL. Meet us and discover how the GARD® assays are transforming skin sensitization testing. Learn about their role in filling data gaps for in vitro skin sensitizing hazard and quantitative potency assessment, providing a high-performing and ethical alternative to animal testing. Exhibitor-Hosted Session Advancing NAMs for Skin Sensitization Testing: […]
Meet us at the 6th Annual BTEL Summit & Exhibition in Berlin. Oral presentation | 26 March Building confidence in New Approach Methodologies (NAMs) for biological safety testing of Medical Devices: a successful case study on skin sensitization testing using GARD® Andy Forreryd, PhD Scientific Liaison Manager, SenzaGen